Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

People In Brief

This article was originally published in The Gray Sheet

Executive Summary

Syncardia: Maker of the Total Artificial Heart names Michael Garippa president July 2. Garippa was former CEO of CardiacAssist, developer of the TandemHeart ventricular assist system. Rodger Ford will continue on as Syncardia's CEO. The firm decided to make the change after the start of an FDA pre-market trial of its Freedom portable driver and after receiving CE approval to market the device in Europe. According to Syncardia, Garippa took CardiacAssist from an R&D firm that had lost an aggregate $50 million to a successful firm with over $6 million in net income in the past 24 months. He is replaced at CardiacAssist by Kraig McEwen
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT029119

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel